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1. Abstract 26 
Yersinia ruckeri, the causative agent of enteric red mouth disease (ERM), is a widely studied 27 
pathogen in disease models using rainbow trout. This infection model, mostly based on 28 
intraperitoneally injection or bath immersion challenges, has an impact on both components 29 
(innate and adaptive) of the fish immune system. Although there has been much attention in 30 
studying its host-pathogen interactions, there is still a lack of knowledge regarding the impact of a 31 
cohabitation challenge. To tackle this we used a newly established non-lethal sampling method 32 
(by withdrawing a small amount of blood) in rainbow trout which allowed the individual immune 33 
monitoring before (non-infected) and after infection with Yersinia ruckeri either by intraperitoneal 34 
(i.p.) injection or by cohabitation (cohab). A range of key immune genes were monitored during 35 
the infection by real-time PCR, and results were compared between the two infection routes. 36 
Results indicated that inflammatory (IL-1β1 and IL-8) cytokines and certain antimicrobial 37 
peptides (cathelicidins) revealed a different pattern of expression between the two infected groups 38 
(i.p. vs cohab), in comparison to adaptive immune cytokines (IL-22, IFN-γ and IL-4/13A) and β-39 
defensins. This suggests a different involvement of distinct immune markers according to the 40 
infection model, and the importance of using a cohabitation challenge as a more natural disease 41 
model that likely simulates what would occur naturally in the environment. 42 
2. Introduction 43 
Yersinia ruckeri is the causative agent of enteric red mouth disease (ERM), also known as 44 
yersiniosis, affecting mainly salmonids. Infection with this bacterium can cause high mortalities in 45 
salmonid aquaculture leading to significant economic losses in the trout farming industry [1-3]. 46 
The bacteria enters the host initially through the epithelial gill cells [4]. The disease causes general 47 
septicaemia in the host as bacteria spread through the body via the blood, resulting in an 48 
inflammatory response in most tissues, with haemorrhaging on the surface of the body and oral 49 
cavity, the latter giving the name “red mouth” to the disease [2, 3]. Host inflammatory responses 50 
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in rainbow trout infected with Y. ruckeri have been reported through the up-regulation of a range 51 
of inflammatory cytokines such as interleukin (IL)-1 family members, IL-6, IL-8, IL-10 and IFN-γ 52 
[3, 5, 6]. Another component of immunity has also been investigated, namely cytokines potentially 53 
involved in adaptive immune responses, such as IL-22 and IL-17A/F2, that are reported to be 54 
induced after infection with the same pathogen [7, 8]. While most studies have focused on 55 
analysing responses in lymphoid tissues, knowing that blood plays a crucial role in spreading the 56 
bacteria, it is suggested that more attention should be paid to this site of immune cells. In fact, 57 
work by Raida et al [9] and Collet et al [10] undertook gene expression analysis in blood samples 58 
and confirmed that blood sampling also allows a sensitive detection of immune markers for the 59 
purpose of health monitoring. Although many studies have been undertaken in the past years to 60 
investigate host-pathogen interactions that occur during ERM infection, most studies focussed on 61 
pathogen challenges using an intraperitoneal (i.p.) injection [5, 7, 8] or bath immersion of the 62 
bacteria [6, 8, 9]. In the natural environment, transmission of ERM occurs through direct contact 63 
between fish and infected carriers, with Y. ruckeri able to survive and remain infective in the 64 
aquatic environment for long periods of time (more than 4 months), through its presence in faeces 65 
of infected animals and microfilms [3, 11]. Cohabitation is a more natural infection model that 66 
resembles what occurs in nature and is well established for other bacterial diseases such as 67 
Aeromonas salmonicida, where it is recommended for use in vaccine efficacy testing [12, 13]. 68 
However, reported studies undertaking a cohabitation challenge with Y. ruckeri are very limited, 69 
and are focussed on testing the efficiency of probiotic diets in promoting disease resistance [14]. 70 
To simulate what would occur naturally in the environment, a cohabitation challenge model was 71 
undertaken in this study and the impact on a range of host immune genes determined. A recently 72 
reported non-lethal sampling method in Atlantic salmon [10] and rainbow trout [15] was adapted 73 
in this study, allowing sequential withdrawal of small amounts of blood from infected fish, to 74 
study key aspects of immunity (e.g. innate and adaptive immune components) in the same 75 
individual throughout the bacterial challenge. In addition, a comparison of the level of immunity 76 
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observed between non-injected (cohabitants) and i.p. injected (shedders) fish at the transcript level 77 
was undertaken, providing further insights into the impact of the route of infection on fish immune 78 
responses. 79 
          3.    Methods 80 
Fish maintenance 81 
Rainbow trout (Oncorhynchus mykiss) (average weight 245.6±0.64 g; average total length 275.6± 82 
0.19 cm) were purchased from Almond bank (Perthshire) and maintained in 1-m diameter aerated 83 
fibreglass tanks supplied with a continuous flow of recirculating freshwater at 14 ± 1 ºC within the 84 
aquarium facility in the School of Biological Sciences (University of Aberdeen). Fish were fed 85 
twice daily on standard commercial pellets (EWOS, Scotland), and were given a 1-week 86 
acclimatisation period prior to treatment. Prior to the bacterial challenge, fish were transferred into 87 
3 tanks (20 fish/tank) in the freshwater aquarium pathogen containment facility and fed as above, 88 
except on the day of the challenge. After the acclimatisation period, fish were anaesthetised with 89 
MS222 (0.08 g/L, Sigma-Aldrich, U.K.) and a Passive Integrated Transponder (PIT)-tag 90 
(BioMark, Europe) was inserted into the peritoneal cavity to allow individual identification. Fish 91 
were allowed to recover for at least 1 week after this procedure.  92 
Bacteria and challenge experiment 93 
A pathogenic strain (MT3072) of the Gram-negative salmonid pathogen Yersinia ruckeri was 94 
used. A stock of bacteria stored in phosphate buffered saline (PBS) containing 15% glycerol was 95 
prepared and maintained at -80°C as described previously [16]. Briefly, 2 days before the 96 
challenge an aliquot of the bacteria was grown in tryptic soy broth medium at 22 ºC in a shaker 97 
incubator. After 2-days, the bacterial suspension was serially diluted in sterile PBS until the stock 98 
bacteria contained ~107 colony forming units (cfu)/mL. For the challenge, thirty rainbow trout 99 
were anaesthetised with MS222 (as described above), and injected intraperitoneally (i.p.) with 6.8 100 
x 106 cfu/mL of Y. ruckeri in PBS (0.1 mL/fish). The fish were divided into 3 tanks (10 fish/tank). 101 
Ten further fish were added into each tank, which were not injected with bacteria, to act as 102 
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cohabitating fish. Past studies using rainbow trout in cohabitation challenges have used a range of 103 
ratios of infected to cohabitants, from 1:5 [14] to 3:1 [17] according to the pathogen used and the 104 
purpose of the study (e.g. testing vaccine efficacy). In this study, since the purpose was to evaluate 105 
and compare the immune response observed in both cohabitant and injected groups, a ratio of 1:1 106 
was used. Fish were checked several times a day post-challenge and removed from tanks when at 107 
least two signs of the disease were observed to avoid any unnecessary suffering, and were 108 
humanely euthanized (Schedule 1 killing method) when appropriate. External symptoms included 109 
haemorrhages in the oral cavity, reddening at the base of the fins, abnormal swimming behaviour 110 
and dark coloration as reported by Kumar et al [3]. 111 
Individual monitoring through non-lethal sampling 112 
Thirty fish from each group (shedders and cohabitants) were anaesthetised with MS222 (0.08 g/L, 113 
Sigma-Aldrich, U.K.) and identified with a PIT-tag reader (Biomark, Europe). The sampling 114 
method followed a similar procedure to that reported recently [15]. In detail, 150 µL of blood 115 
(<1% blood volume) was collected from the caudal vein immediately before the infection with 116 
bacteria was undertaken, corresponding to the uninfected day 0 (D0) sampling point. This 117 
provided a control for each individual fish that would not be possible with lethal sampling. Blood 118 
was also collected 3 days after infection (D3) and at a terminal point (between days 4 and 7), when 119 
fish died or were euthanized after showing at least two external signs of disease. After sampling, 120 
blood was immediately transferred into heparinised vaccutainers (Midmeds Ltd, U.K.) and kept on 121 
ice until RNA extraction was undertaken. Fish were monitored closely after sampling until they 122 
were fully recovered from the anaesthesia.  123 
Verification of the cause of death 124 
Fish started to show symptoms of the disease from day 3 after infection, and all fish died or were 125 
euthanized within 7 days post-infection. To confirm cause of death/morbidity swabs were taken 126 
from the kidney of a proportion of the fish and plated onto tryptic soy agar plates, and incubated 127 
for 48h at 22 ºC. Colony PCR was performed using species specific primers for the Y. ruckeri 16s 128 
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RNA (Table 1) and the products visualised after electrophoresis in an agarose gel containing 129 
ethidium bromide. DNA was extracted from head kidney samples using a DNA extraction kit 130 
(Qiagen, U.K.), performed using the manufacturer’s instructions. The head kidney bacterial 131 
burden of all samples was assessed by real-time PCR using Y. ruckeri 16s RNA specific primers, 132 
with the data normalised to the expression of the host MCSF1 gene as described by Harun et al 133 
[18] and Gibello et al [19] (Table 1). Due to the occurrence of high mortalities observed from day 134 
3 and to the inability of obtaining a fresh blood sample from all fish after this time point, only 22 135 
fish were successfully bled on three occasions per treatment group and used for real-time PCR 136 
analysis. 137 
RNA extraction and cDNA synthesis 138 
RNA from blood samples was extracted using an adapted method from that given in the RNeasy 139 
Mini kit (Qiagen, U.K.). Briefly, 30 µL of blood were lysed in RLT buffer (RNeasy kit, Qiagen, 140 
U.K.) containing 10 % (v/v) β-mercapto-ethanol (Sigma-Aldrich, U.K.), and homogenised in a 141 
Tissue Lyser using a 5-mm bead (Qiagen, U.K.) for 1 min at 25 Hz at room temperature. The 142 
remaining steps were undertaken following the manufacturer’s instructions, and RNA was eluted 143 
in 75 µL of RNAse-free water (Qiagen, U.K.) and stored at -80ºC until further use. cDNA was 144 
synthetized using M-MuLV Reverse Transcriptase (New England Biolabs, U.K.) and oligo-d(T)16 145 
primer (Applied Biosystems, Europe). For this 8 µL of RNA (approximately 0.5 µg) were mixed 146 
with 1 µL 10 mM dNTPs (Applied Biosystems, Europe) and 2 µL H2O, incubated at 65ºC for 5 147 
min, and put immediately on ice. The final volume was adjusted to 20 µL by adding Reverse 148 
Transcriptase buffer, 10 mM DTT, 0.5 mM each dNTP, 0.5 U RNase inhibitor (Applied 149 
Biosystems, Europe) and 200 U M-MuLV Reserve Transcriptase (New England Biolabs, U.K.). 150 
The final mix was incubated at 95ºC for 5 min and then at 37ºC for 90 min. The obtained cDNA 151 
was stored at -20ºC until further use. 152 
Real-time PCR and data analysis 153 
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Real-time PCR was performed using IMMOLASE (Bioline, U.K.) and SYBR Green fluorescent 154 
tag (Invitrogen, U.K.) in a LightCycler® 480 System (Roche Applied Science, U.K.). To obtain 155 
the expression level of the genes of interest, a standard curve was constructed for each immune 156 
gene using serially diluted purified PCR products, amplified from cDNA. The obtained standards 157 
were run in duplicate in the same 96-well plate along with the cDNA samples from the challenged 158 
fish, and served as reference for quantification. Transcript level was calculated using the 159 
integrated software. The relative expression of immune genes was calculated as arbitrary units and 160 
normalised against the expression level of rainbow trout elongation factor (EF)-1α, a house 161 
keeping gene. All normalised data were multiplied by 1,000 due to the low level of expression 162 
found in certain genes. Primers for real-time PCR were designed and pre-tested to ensure they 163 
could not amplify genomic DNA, as described by Wang et al [20]. Immune markers selected for 164 
real-time PCR analysis included cytokines involved in inflammatory (IL-1β1, IL-6 and IL-8), and 165 
adaptive immune responses, with key markers for each putative TH subset selected (IFN-γ, IL-166 
4/13A, IL-22 and IL-17A/F2). The antimicrobial peptides β-defensin (BD)-3 and BD-4, and 167 
cathelicidins (Cath)-1 and Cath-2 were also analysed in this study. The bacterial load in blood was 168 
also evaluated by real-time PCR, which has been reported to allow a successful detection of Y. 169 
ruckeri in blood samples [9, 21]. Sequences of primers used are listed in Table 1.  170 
Statistical analysis 171 
The expression data was analysed statistically using a general linear model (GLM) for repeated 172 
measures test to determine the overall time effect of infection and to evaluate the interaction 173 
between delivery routes. Data were Log2 transformed in order to meet the GLM assumptions of 174 
homogeneity, sphericity and independency. Statistical significance was taken as a P value of 175 
<0.05. Additionally, a paired T-test was used to test for significant differences between the 176 
bacterial load in cohabitation and i.p. injection infected groups, where a P < 0.05 indicated 177 
significant differences between the two groups (n=22). In addition to analysing gene changes 178 
during infection, a correlation analysis of expressed genes in infected fish was undertaken to 179 
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investigate the relationship between gene expression and pathogen load. For this a correlation 180 
between bacterial load in blood and gene expression level of immune markers was analysed 181 
separately in fish infected by cohabitation or injection, calculating the Pearson correlation 182 
coefficient (r) with a P < 0.05 (2-tailed) considered statistically significant. A Log2 transformation 183 
was also undertaken to improve normality in the data, and the transformed data is presented in the 184 
figures. Lastly, a correlation study was applied to compare the pathogen load between terminal 185 
head kidney samples and blood. All statistical analysis was performed with SPSS software 186 
Version 23 (IBM Corporation, USA). 187 
4. Results 188 
In this study a non-lethal sampling method was used to compare two distinct routes of infection 189 
(i.p. injection vs cohabitation) with Yersinia ruckeri, the causative agent of enteric red mouth 190 
disease (ERM). Thirty rainbow trout (10 per tank) were challenged by i.p. infection with Y. 191 
ruckeri strain MT3072, and were left to cohabitate with 30 non-infected fish (10 per tank). Results 192 
revealed that mortalities (fish found dead or killed by a Schedule 1 method) were first observed 3 193 
days after infection in the i.p. injected group (Figure 1) when 5 mortalities occurred. Mortalities 194 
in the cohabitation group were observed 1 day later (7 mortalities). The peak of mortalities 195 
occurred at days 4 (10 mortalities) and 5 (17 mortalities) for the injection and cohabitation groups, 196 
respectively. The experiment was terminated at 7 days post-infection, since all fish were either 197 
found dead or were culled due to the presence of symptoms of the disease, such as haemorrhages 198 
in the oral cavity, abnormal swimming behaviour and reddening at the base of the fins by this 199 
time. Internally, fish revealed symptoms such as haemorrhaging, enlarged spleen and inflamed 200 
tissues. Due to the observed high mortalities only 22 fish per treatment group were successfully 201 
sampled on three occasions and used to perform cDNA synthesis and real-time PCR analysis. 202 
To confirm the pathogen load in the host, the head kidney was collected at the terminal 203 
sampling point and the bacterial load evaluated by real-time PCR. Results indicated that the 204 
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expression of Y. ruckeri 16s RNA relative to the host MCSF1 expression was significantly higher 205 
(121-fold increase) in i.p. injected fish relative to fish infected by cohabitation (Figure 2A). Since 206 
a non-lethal sampling method was used, it was also possible to detect the presence of the bacteria 207 
in the blood during the course of this experiment, by detecting the expression of Y. ruckeri 16s 208 
RNA relative to the EF-1α expression (Figure 2B). For this a small volume of blood was 209 
collected from naïve rainbow trout before (corresponding to a true baseline control) and after 210 
infection with bacteria. Blood samples from the forty-four rainbow trout where the full range of 211 
samples had been collected (i.e. day 0, day 3, and at the terminal point), were analysed. 212 
Quantification of the Y. ruckeri 16s RNA in blood indicated that the detection of bacterial load 213 
increased significantly (P < 0.01) at day 3 and the final sampling point post-infection (using a 214 
repeated measures statistical test), but no bacteria were detected in either treatment group at day 0 215 
(before infection) (Figure 2B). A significant interaction between route of infection and pathogen 216 
load (P < 0.01, F = 13.14) at the terminal time point was also noted, where the injected fish had a 217 
higher pathogen load compared to the cohabitation group. Correlation analysis comparing the 218 
pathogen load obtained in the head kidney and blood in these rainbow trout at the terminal 219 
sampling point (Figure 3), showed a significant positive correlation (r = 0.537) in the injected fish 220 
but not in the cohabitation fish. 221 
  Expression of selected immune genes was undertaken using real-time PCR in order to 222 
enable an overall evaluation of immunity over time in the same individual fish after challenge, and 223 
to investigate the effect of the route used for infection (i.p. vs cohabitation). The expression of IL-224 
1β1, a potent pro-inflammatory cytokine, using a repeated measures test indicated that its 225 
expression was significantly affected over time (P < 0.01, F = 13.1) (Figure 4A, Table 2). We 226 
also observed that there was a significant interaction between time and infection route (P < 0.01, F 227 
= 11.4), where the i.p. injection group (average relative expression of 49.88, Supplementary 228 
Material) showed a significant up-regulation of IL-1β1 expression in comparison to the 229 
cohabitation group (average relative expression of 4.5, Supplementary Material). A similar 230 
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pattern of expression was observed while monitoring another pro-inflammatory cytokine, IL-8 231 
(Figure 4A, Table 2). An additional cytokine involved in inflammatory reactions (IL-6) was 232 
analysed (Figure 4A, Table 2), and although it revealed a similar pattern of expression over time 233 
(P < 0.01, F = 48.62), there was no significant difference between the injected and cohabitation 234 
groups (P > 0.05, F = 0.83) (Table 2). Cytokines representative of each putative TH cell subset 235 
were also analysed (TH1, TH2 and TH17). Monitoring of IFN-γ, a key TH1 cytokine, indicated that 236 
there was an effect of infection time on its expression (P < 0.01, F = 69.5) (Figure 4B). However, 237 
there was no interaction between time after infection and the route used (P > 0.05, F= 2.4), with 238 
both cohabitation and injected groups having an upregulation of IFN-γ expression at the terminal 239 
time point. A representative of the TH2 subset, IL-4/13A was also investigated and real-time PCR 240 
results revealed that although there was an effect of infection over time, there was no difference 241 
between the infected groups (Figure 4B, Table 2). When analysing two putative TH17 cytokines 242 
(IL-22 and IL-17A/F2), the results indicated that IL-22 expression was significantly up-regulated 243 
(P < 0.01, F = 117.1) at the terminal time point, with average relative expressions of 0.84 and 0.59 244 
observed for the injected and cohabitation infected groups, respectively (Figure 4B, 245 
Supplementary Material). However, there was no significant difference between the two 246 
infection routes (P > 0.05, F = 0.65). In the case of IL-17A/F2, only low expression values were 247 
obtained in the blood samples (Cp values higher than 35), and so the results were considered 248 
unreliable (Figure 4B, Table 2). These findings suggest that the route of infection did not affect 249 
the expression of these cytokines of adaptive immunity. 250 
In addition to the analysed cytokines, several antimicrobial peptides (β-defensins and 251 
cathelicidins) were also investigated, due to their important role in mucosal immunity against 252 
bacterial pathogens. Regarding the effect of the challenge on the β-defensins (BD-3 and BD-4), a 253 
similar pattern was observed whereby there was a significant effect (P < 0.01, F = 21.2 and P < 254 
0.01, F = 40.9, respectively) of the bacterial infection on their expression during the experiment 255 
(Figures 4C) but no statistical difference was found between the two routes used for infection. 256 
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Another antimicrobial peptide family, the cathelicidins (Cath-1 and Cath-2), was analysed and 257 
both genes studied revealed a similar effect (Figures 4C, Table 2). However, interestingly, a 258 
significant difference (P < 0.01) between the two infected groups was found, with a higher 259 
significant induction of both Cath-1 and Cath-2 expression in the injected group (average 260 
expression of 1.3 and 1.25, respectively) vs the cohabitation group (average expression of 0.06 261 
and 0.14, respectively) at the terminal time point (Figures 4C, Supplementary Material).  262 
To evaluate the relationship between immune gene expression and pathogen load a 263 
correlation analysis was undertaken using data from all time points. Results indicated that the 264 
inflammatory cytokines IL-1β1 and IL-6 showed a positive correlation (statistically significant) 265 
with the pathogen load in the i.p. infected group (r = 0.455 and r = 0.543, respectively) (Figures 266 
5A and 5B). When analysing the cohabitation group, no correlation was observed for IL-6 267 
expression whereas IL-1β1 was negatively correlated (r = -0.403) (Figures 6A and 6B). A similar 268 
result was observed when analysing IL-8, where a positive correlation (r = 0.573) was only 269 
observed in the i.p. group but not in the cohabitant fish (Figures 5C and 6C). The adaptive 270 
immune cytokines (IFN-γ, IL-4/13A and IL-22) showed a different pattern, where a positive 271 
correlation between their expression and the bacterial load was observed in both treatment groups 272 
(Figures 5D-F and 6D-F) and was highly significant (i.e. P < 0.01). A significant correlation 273 
pattern was also observed for BD-4 (Figures 5H and 6H), with both cohabitant and i.p. groups 274 
being positively correlated with pathogen load, whereas BD-3 was only correlated in the i.p. group 275 
(Figures 5G and 6G). In the case of the cathelicidins Cath-1 and Cath-2, a significant correlation 276 
between the i.p. group and pathogen load was also found but again was not observed in the 277 
cohabitant group (Figures 5I, J and 6I, J). 278 
5. Discussion 279 
In this study a recently established non-lethal sampling method was used to monitor aspects of the 280 
immune response in individual fish before (control) and after bacterial infection. The pathogen 281 
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used was Y. ruckeri, the causative agent of ERM, an economically important disease in the trout 282 
farming industry [1-3]. The only study to date undertaking a similar approach to evaluate immune 283 
responses in individual rainbow trout, was a study by Raida et al [9]. However, the design of their 284 
experiment was significantly different, as only one non-lethal sampling was undertaken (at day 3 285 
post-infection) and fish were subjected to a bath (immersion) challenge. The method used in this 286 
study, of withdrawing a small volume of blood (150 µL), has been recently optimised in Atlantic 287 
salmon [10] and was found to be very successful to monitor cytokine expression individually in 288 
fish experimentally infected with a virus.  289 
In the present study mortalities resulting from the disease were first recorded in the 290 
intraperitoneally (i.p.) injected group at day 3, and started one day later in the cohabitation group. 291 
This is in agreement with previous studies where rainbow trout infected by injection or bath 292 
showed the first mortalities from day 3 [4, 9, 18]. That the mortalities in the cohabitation group 293 
began from day 4 may be due to the high ratio (infected vs non-infected) used in this study. In 294 
terms of bacterial load, it was possible to detect the presence of Y. ruckeri 16s RNA in blood 3 295 
days post-infection, and at the terminal time point, by real-time PCR. This was also seen by Raida 296 
et al [6] who detected the presence of this bacterium (~ 0.25 x 105 cfu/mL) as early as 2 days post-297 
infection by plating 10 µL blood samples onto blood agar plates. The injected group had a higher 298 
expression level of Y. ruckeri 16s from both blood and head kidney samples collected at the 299 
terminal sampling point, when compared to the cohabitation group, as expected. However, this 300 
route of delivery is probably not a good model of natural infection compared to bath or 301 
cohabitation. For example, injection bypasses natural mucosal defences of the host, such as skin 302 
and mucus [22]. Indeed, studies of vaccine efficacy in salmonids have used cohabitation as a 303 
model of infection and show that this model, as well as bath challenge, mimics well what occurs in 304 
the environment/ fish farms [12, 13, 23]. Findings in this work also suggest that, as reported by 305 
others [3, 11], transmission of ERM might occur through direct contact between i.p. infected and 306 
non-infected fish, possibly by shedding the bacterium through faeces. However, other 307 
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transmission routes, such as the formation of biofilms, are also possible. This highlights the 308 
importance of using cohabitation disease models for future studies to provide further clues about 309 
the mode of transmission of this bacterium. 310 
It has been suggested that the spleen plays a major role against bacterial pathogens, such as 311 
Y. ruckeri, with its enlargement during infection due to potential recruitment of immune cells 312 
activated by inflammatory cytokines [6, 18, 24, 25]. However, a recent study showed that Y. 313 
ruckeri can be detected in the blood and gill epithelial cells within 1 minute post-infection using 314 
Optical Projection Tomography and immunohistochemistry [4]. In the same study, severe 315 
septicaemia was observed 7 days post-infection, with bacteria found in a wide range of organs 316 
such as liver, spleen and heart [4]. This suggests that blood aids the rapid spread of the infection 317 
into the internal organs. Indeed up-regulation of inflammatory cytokine transcript levels has been 318 
reported in the blood of Y. ruckeri bath challenged trout, sampled 3 days post-infection, that 319 
subsequently did not survive [9]. Therefore, in this study an optimised non-lethal blood sampling 320 
approach was used to evaluate the immune responses between cohabitation and i.p. injection 321 
challenged fish, by monitoring blood samples before (control) and after infection (infected group).  322 
Real-time PCR analysis of blood samples found that the pro-inflammatory cytokines IL-323 
1β1 and IL-8 were induced over time, during the infection. Other studies [6, 9, 18] also found that 324 
both cytokines were highly up-regulated at different time-points upon i.p. injection or bath 325 
challenge with Y. ruckeri in spleen and blood confirming their involvement in the host response to 326 
bacterial infection. Our previous work using a similar sampling method with virus infected 327 
Atlantic salmon reported that none of these cytokines were induced during the course of the 328 
experiment, with blood sampling points at 0, 4, 8, 12, 16, 21 and 25 days after challenge [10]. This 329 
demonstrates that the blood sampling procedure is not inducing cytokine transcription by itself and 330 
that very different host responses are seen dependent upon the pathogen encountered. In this study 331 
we also show that the route of infection (injection vs cohabitation) used had a differential effect on 332 
the transcript level of IL-1β1 and IL-8, with the injected group revealing a high induction over the 333 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
non-injected fish. It is known that injection with bacteria induces an influx of neutrophils and 334 
macrophages into the peritoneal cavity of rainbow trout, where they mediate phagocytosis [6, 26]. 335 
This confirms the relevance of the infection method used and its effect on the secretion of 336 
inflammatory cytokines, such as IL-1β1 and IL-8, in order to attract phagocytes (e.g. neutrophils) 337 
to the local site of infection [27, 28]. The findings were in agreement with the positive correlation 338 
observed between the pathogen load and the gene expression of IL-1β1 and IL-8 in the i.p. group, 339 
which was not observed in the cohabitants. In fact, a negative correlation was observed for IL-1β 340 
in the cohabitant fish.  341 
Interestingly, a different result was observed when analysing the adaptive immunity 342 
cytokines, IL-22, IFN-γ and IL-4/13A, where such cytokines showed a similar pattern of induction 343 
in both injected and cohabitation groups. This was in agreement with the correlation analysis, with 344 
the three cytokines showing a positive significant correlation with the bacterial load in both 345 
injected and cohabitation groups. This suggests that a common mechanism of adaptive defence is 346 
induced independent of the infection route. Previous studies have also reported the involvement of 347 
these cytokines upon infection with Y. ruckeri by i.p. injection [6, 7, 17] and bath challenge [29], 348 
suggesting the response is of a multi-faceted nature during lethal bacterial infections where the 349 
host may throw everything in its’ armoury at the pathogen in a last ditch attempt to survive. 350 
Possibly these cytokines are secreted into the host’s circulation to promote both local and systemic 351 
immunity via innate lymphoid cell or TH-driven responses. Overall, findings in this study 352 
emphasize the importance of undertaking a comparative study between two commonly used 353 
delivery routes and provides an insight for future studies aiming at evaluating the efficacy of 354 
vaccines. 355 
 In addition to the studied cytokines, several antimicrobial peptides, likely involved in 356 
promoting innate immune responses against bacterial infections were also studied [30, 31]. The 357 
results showed that both β-defensins studied (BD-3 and BD-4) had a similar pattern of expression, 358 
being induced in both infection models. Since it is expected that infection by cohabitation will 359 
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allow the host surface defences to respond to the pathogen, this may explain why molecules 360 
potentially involved in mucosal immunity, such as β-defensins [31], as well as IL-22 [7], may be 361 
highly induced using this challenge route. Moreover, trout recombinant IL-22 has been shown to 362 
be induce the expression of both BD-3 and BD-4 in spleen, confirming the potential relationship 363 
between these molecules [7]. To obtain a more general understanding of the roles of AMPs in the 364 
responses two further genes from the cathelicidin family (Cath-1 and Cath-2) were analysed and, 365 
interestingly, revealed a differential expression pattern dependent upon the route of infection, with 366 
injected fish having a significantly higher induction vs the cohabitation fish. This result was 367 
confirmed by the correlation analysis, where a significant positive correlation between the 368 
bacterial load and gene (Cath-1, Cath-2) expression was observed only in the injected fish. A 369 
study by Bridle et al [32] reported that cathelicidins were able to stimulate the expression of IL-8 370 
in Atlantic salmon peripheral blood leucocytes, and suggested that both Cath-1 and Cath-2 are 371 
involved in promoting local responses by recruiting immune cells through IL-8 activation. The 372 
similar patterns of gene expression induction observed here between cathelicidins and IL-8 are in 373 
concordance with these findings. Moreover, since injection of pathogens bypasses the natural 374 
mucosal defences, it is possible that cathelicidins may have a more important role in promoting 375 
immune responses when infections become systemic, whereas β-defensins may be important for 376 
both local and systemic defence.  377 
 In conclusion, this study used a non-lethal sampling method to compare the immune 378 
responses elicited in two infection models, i.p. injection and cohabitation. Immune gene transcript 379 
levels indicated that adaptive cytokines have a different pattern of expression when compared to 380 
pro-inflammatory cytokines, dependent on the infection model. Interestingly, the antimicrobial 381 
peptides studied also act differently in these two infection models, indicating different defence 382 
mechanisms are activated when mucosal or systemic pathogen detection occurs. Thus, in future 383 
studies attention should be drawn to the infection models used, taking into consideration that 384 
cohabitation models likely reflect a more natural infection route. However, to provide a more 385 
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comprehensive study, future work should also include infection by immersion, which would 386 
highlight any potential differences/similarities between two less-invasive infection models. 387 
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 492 
Figure legends 493 
Figure 1. Cumulative mortality of rainbow trout following bacterial challenge with Yersinia 494 
ruckeri (MT3072). Thirty rainbow trout were infected with Y. ruckeri by intraperitoneal injection 495 
(106 cfu/mL) or by cohabitation (cohab).  496 
Figure 2. Pathogen load in head kidney and blood of fish infected with Y. ruckeri. A. Total DNA 497 
was extracted from head kidney of bacterially infected rainbow trout by cohabitation (cohab) 498 
(n=22) or intraperitoneal injection (n=22) at the terminal sampling point. Real-time PCR analysis 499 
was undertaken by detecting the expression of Y. ruckeri 16s RNA gene and normalising it to the 500 
host gene MCSF1. A paired T-test was performed, with asterisks indicating a significant 501 
difference (P < 0.05) between cohab and injected groups. B.  RNA was extracted from rainbow 502 
trout blood samples collected before (D0) or after infection with Y. ruckeri, at 3 days post-503 
challenge (D3) and at the terminal point (between days 4 and 7) when fish succumbed to the 504 
disease (Dterm). Synthesized cDNA was used for real-time PCR, normalising the Y. ruckeri 16s 505 
RNA gene expression to the house keeping EF-1α gene. Results are averages + standard error 506 
(n=22 per treatment group). Asterisks indicate significant differences (P < 0.01) relative to day 0 507 
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(D0). The hash symbol indicates there is a significant (P < 0.01) difference between the infection 508 
routes, as determined using a general linear model (GLM) for repeated measures. 509 
Figure 3. Correlation of bacterial load in the head kidney and blood from rainbow trout infected 510 
with Y. ruckeri by intraperitoneal injection (n=22) or cohabitation (cohab) (n=22), at the terminal 511 
time point. Pearson correlation r coefficients are given relative to Y. ruckeri load in the blood. A 512 
significant correlation (P < 0.05) is indicated with an asterisk. 513 
Figure 4. Expression analysis of selected immune genes in individual trout during Y. ruckeri 514 
infection by cohabitation (cohab) or intraperitoneal injection. Blood samples were collected before 515 
infection (Control, D0), at 3 days post-infection (D3) and at a terminal sampling time (Dterm, 516 
between 4 to 7 days post-challenge). RNA was collected for real-time PCR expression analysis, of 517 
pro-inflammatory (A) (IL-1β1, IL-6 and IL-8) and adaptive immunity (B) (IFN-γ, IL-4/13A and 518 
IL-22) cytokines, as well as antimicrobial peptides (C) (BD-3, BD-4 and Cath-2) genes. Results 519 
are presented individually with averages (n=22 fish per group) shown as black and grey bars for 520 
the injection (i.p.) and cohabitation groups, respectively. Cath-2 was selected to be presented 521 
graphically over Cath-1 because it showed a stronger interaction between the routes of infection. 522 
Refer to Table 2 for stats and Supplementary Material for relative expression values. 523 
Figure 5. Correlation of bacterial load and selected immune genes in blood of fish infected with Y. 524 
ruckeri by intraperitoneal injection, across at all time points. Immune markers include IL-1β1 (A), 525 
IL-6 (B), IL-8 (C), IFN-γ (D), IL-4/13A (E), IL-22 (F), BD-3 (G), BD-4 (H), Cath-1 (I) and Cath-526 
2 (J). Pearson correlation r coefficients are given relative to Y. ruckeri load in the blood. 527 
Significant correlations (P < 0.05) are in bold and indicated with an asterisk. n=66 samples (22 528 
fish per time point). 529 
Figure 6. Correlation of bacterial load and selected immune genes in blood of fish infected with Y. 530 
ruckeri by cohabitation, across at all time points. Immune markers include IL-1β1 (A), IL-6 (B), 531 
IL-8 (C), IFN-γ (D), IL-4/13A (E), IL-22 (F), BD-3 (G), BD-4 (H), Cath-1 (I) and Cath-2 (J). 532 
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Pearson correlation r coefficients are given relative to Y. ruckeri load in the blood. Significant 533 
correlations (P < 0.05) are in bold and indicated with an asterisk. n=66 samples (22 fish per time 534 
point). 535 
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Table 1.  Oligonucleotide primers used for expression analysis 
 Forward primer (5′ TO 3′) Reverse primer (3′ TO 5′) Accession 
No: 
16s RNA (Y. 
ruckeri) 
GCGAGGAGGAAGGGTTAAGTG GAAGGCACCAAGGCATCTCT X75275 
MCSF1 ACCCCGTCTGCCACGAATGA CAGCTTGGCCCCAGCAACAG AM901600 
EF-1α CAAGGATATCCGTCGTGGCA ACAGCGAAACGACCAAGAGG AF498320 
IL-1β1 CCT GGA GCA TCA TGG CGT G GCTGGAGAGTGCTGTGGAAGAA
CATATAG 
AJ278242 
IL-4/13A ACCACCACAAAGTGCAAGGAGT
TCT 
CACCTGGTCTTGGCTCTTCACAA
C 
FN820501 
IL-6 CCTTGCGGAACCAACAGTTTG CCTCAGCAACCTTCATCTGGTC DQ866150 
IL-8 AGAATGTCAGCCAGCCTTGT TCTCAGACTCATCCCCTCAGT AJ310565 
IL-17A/F2a CGTGTCGAAGTACCTGGTTGTGT GGTTCTCCACTGTAGTGCTTTTCC
A 
AJ277604 
IL-22 ACAGCAGGTGGCTCAACATGCG CCTTTCCCCTCCTCCATCTCGGA AM748538 
IFN-γ CAAACTGAAAGTCCACTATAAGA
TCTCCA 
TCCTGAATTTTCCCCTTGACATAT
TT 
AJ616215 
BD-3 GCTTGTGGAATACAAGAGTCATC
TGC 
GCATACATTCGGCCATGTACATC
C 
FM212657 
BD-4 TGGTGCTCCTCGCTTTCTTGG TGGGCGACACAGCATACAAATC FM212658 
Cath-1 ACCAGCTCCAAGTCAAGACTTTG
AA 
TGTCCGAATCTTCTGCTGCAA AY594646 
Cath-2 ACATGGAGGCAGAAGTTCAGAA
GA 
GAGCCAAACCCAGGACGAGA AY542963 
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         Table 2. Summary of immune gene expression in Y. ruckeri infected rainbow trout 
Gene Average Cp 
Control D0 
 Overall time effect Interaction 
between i.p. and 
cohab 
EF-1α 12.55 F value 
P value 
N/A N/A 
 
IL-1β1 21.14 F value 
P value 
 13.08 
 0.000 
11.37 
0.000 
IL-4/13A 25.79 F value 
P value 
72.79 
0.000 
            0.907 
0.408 
IL-6 28.71 F value 
P value 
48.62 
0.000 
0.832 
0.439 
IL-8 25.27 F value 
P value 
26.45 
0.000 
4.98 
0.009 
IL-17A/F2a 37.69 F value 
P value 
N/A N/A 
 
IL-22 31.25 F value 
P value 
117.14 
0.000 
0.646 
0.527 
IFN-γ 29.80 F value 
P value 
69.48 
0.000 
2.434 
0.094 
BD-3 23.03 F value 
P value 
21.17 
0.000 
0.267 
0.767 
BD-4 30.29 F value 
P value 
40.88 
0.000 
0.021 
0.979 
Cath-1 25.71 F value 
P value 
14.45 
0.000 
5.02 
            0.009 
Cath-2 27.89 F value 
P value 
8.13 
0.001 
7.89 
0.001 
*Statistically significant differences are highlighted in bold.  
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Figure 6. A. IL-1β1  B. IL-6 
C. IL-8  D. IFN-γ
E. IL-4/13A  
J. Cath-2
G. BD-3 H. BD-4
I. Cath-1
F. IL-22  
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Highlights 
 
 
 
• This study reports sequential immune monitoring of individual fish upon infection; 
• Two infection models (i.p. injection and cohabitation) were used in this study;  
• IL-1β and IL-8 showed a distinct regulation in blood depending on the infection route; 
• Adaptive immunity cytokines revealed a similar expression in both infection models; 
• Cathelicidins and β-defensins act differently depending on the infection model. 
 
 
